Hashimoto K, Shimomura A. Regarding the Addition of CDK4/6 Inhibitor to Postoperative Endocrine Therapy in Patients With HR-Positive HER2-Negative High-Risk Breast Cancer. J Clin Oncol 2021 Feb 25:JCO2003215. doi: 10.1200/JCO.20.03215.
PMID: 33630669